Richard W. Pascoe, President and CEO at Somaxon Pharmaceuticals, Inc. (SOMX), sold 104,510 shares at $9.58 ($625K) on 2010-03-18, disclosed to the SEC on 2010-03-19.
Scheduled sale ($625k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.62 | 76,300 | $429K | 68.6% |
| 2 | $6.42 | 15,100 | $97K | 15.5% |
| 3 | $6.50 | 4,510 | $29K | 4.7% |
| 4 | $7.53 | 4,800 | $36K | 5.8% |
| 5 | $8.74 | 2,600 | $23K | 3.6% |
| 6 | $9.58 | 1,200 |
| $11K |
| 1.8% |
| Total | $5.98 avg | 104,510 | $625K | 100% |
| Filing → |
| KMPH | BUY | 2022-05-18 | $23K | — | Filing → |
| KMPH | BUY | 2021-11-30 | $12K | — | Filing → |
| HSTO | BUY | 2021-03-30 | $23K | — | Filing → |